Obagi Medical Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Valeant
Mar 20th 2013 10:35AM
Updated Mar 20th 2013 10:40AM
Obagi Medical Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Valeant Pharmaceuticals
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Obagi Medical Products, Inc. ("Obagi") (NasdaqGS: OMPI) to Valeant Pharmaceuticals International, Inc. for shareholders. Under the terms of the proposed transaction valued at approximately $360 million, Obagi shareholders will only receive $19.75 in cash for each share of stock owned.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com, or Zach Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at firstname.lastname@example.org. There is no cost or fee to you.
The Obagi sale investigation centers on whether Obagi's shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Obagi's stock, and whether Obagi's board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. Shareholder rights attorney Willie Briscoe commented that "based upon the proposed sale price, recent financial performance, and other factors, we believe this transaction may undervalue Obagi's stock. Our proposed lawsuit will seek to ensure that shareholders are receiving the highest share price for their shares."
The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.
KEYWORDS: United States North America Texas
The article Obagi Medical Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Valeant Pharmaceuticals originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.